Literature DB >> 22197092

The size does not matter - the presence of microvascular obstruction but not its extent corresponds to larger infarct size in reperfused STEMI.

Łukasz A Małek1, Mateusz Śpiewak, Mariusz Kłopotowski, Jolanta Miśko, Witold Rużyłło, Adam Witkowski.   

Abstract

BACKGROUND: Microvascular obstruction (MVO) is a cardiac magnetic resonance (CMR) marker of no-reflow in ST-segment elevation myocardial infarction (STEMI). It remains unresolved whether the infarct size corresponds only to the presence of MVO or also to its extent.
METHODS: The study included 53 patients with first STEMI (median age 61.5 years, 77% male) treated with percutaneous coronary intervention (PCI) who underwent CMR after median 5 days from PCI. Small MVO was defined as patchy, non-confluent spots of dark areas of absent contrast surrounded by late gadolinium enhancement (LGE). Large MVO was defined as confluent areas of MVO comprising a large amount of the infarct zone.
RESULTS: Microvascular obstruction was observed in 32 patients (60%) including 18 patients with small MVO (36%) and 14 patients with large MVO (24%). Patients with MVO were more likely to have TIMI 0/1 grade flow on initial angiogram, higher levels of necrotic markers, larger infarct size, larger left ventricular end-diastolic and end-systolic volume and lower ejection fraction in comparison to patients without MVO. These differences were not observed between patients with large and small MVO.
CONCLUSIONS: The presence of MVO but not its extent corresponds to larger infarct size in STEMI.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197092     DOI: 10.1016/j.ejrad.2011.11.053

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  MRI quantification of left ventricular function in microinfarct versus large infarct in swine model.

Authors:  Maythem Saeed; Steve W Hetts; Loi Do; Sammir M Sullivan; Mark W Wilson
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-13       Impact factor: 2.357

Review 2.  Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis.

Authors:  Yasmin S Hamirani; Andrew Wong; Christopher M Kramer; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2014-09

3.  Comparison between visual grading and planimetric quantification of microvascular obstruction extent assessment in reperfused acute myocardial infarction.

Authors:  Marc Sirol; Heger Gzara; Etienne Gayat; Raphael Dautry; Barnabas Gellen; Damien Logeart; Philippe Soyer; Eric Vicaut; Jean-Jacques Mercadier
Journal:  Eur Radiol       Date:  2015-12-10       Impact factor: 5.315

4.  Assessment of the longitudinal changes in infarct heterogeneity post myocardial infarction.

Authors:  Idan Roifman; Nilesh R Ghugre; Tasnim Vira; Mohammad I Zia; Anna Zavodni; Mihaela Pop; Kim A Connelly; Graham A Wright
Journal:  BMC Cardiovasc Disord       Date:  2016-10-14       Impact factor: 2.298

5.  Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI.

Authors:  Wenbo Liu; Zhipeng Zou; Haipeng Jiang; Qiang Li; Fangming Guo; Zhen Wang; Hongguang Zhu
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

Review 6.  Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction.

Authors:  Jamal N Khan; Gerry P McCann
Journal:  World J Cardiol       Date:  2017-02-26

7.  Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.

Authors:  X J Zhao; X L Liu; G X He; H P Xu
Journal:  Braz J Med Biol Res       Date:  2014-02-14       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.